July 29,2019
Pharma14 tracking of new Hematology drug market authorizations.
2018 has seen a record number of new medicines approved by the FDA.
18 new Hematology novel drugs and biologics were approved last year.
Combining 2017, 2018 and 2019, the FDA has approved 37 new Hematology drugs.
As the number of new Hematology drugs coming onto market is increasing each year, Pharma14 has undertaken a specific program to track and list these new products immediately as they become registered MA’s among the 42 countries we cover.
Sample data: Cablivi, Caplacizumab. Ex-factory, wholesale and retail pricing prices in selected markets.
